Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

NMD Pharma announces topline results from its Phase 2a study of ignaseclant in ...

Summary by Hastings Tribune
Exploratory Phase 2a study showed consistent and clinically meaningful functional improvements across muscle strength, motor performance, and patient-reported outcomes in patients with Charcot-Marie-Tooth disease (CMT)Benefits emerged early, were durable beyond treatment discontinuation, and were supported by patient-reported outcomes, with ignaseclant…

1 Articles

Hastings TribuneHastings Tribune
Center

NMD Pharma announces topline results from its Phase 2a study of ignaseclant in ...

Exploratory Phase 2a study showed consistent and clinically meaningful functional improvements across muscle strength, motor performance, and patient-reported outcomes in patients with Charcot-Marie-Tooth disease (CMT)Benefits emerged early, were durable beyond treatment discontinuation, and were supported by patient-reported outcomes, with ignaseclant…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Hastings Tribune broke the news in on Tuesday, February 3, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Hastings, Nebraska icon

Hastings, Nebraska

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal